Synopsis Day 1: 2018 Annual World Medical Innovation Forum Artificial Intelligence April 23–25, 2018 Boston, Massachusetts | Westin Copley Place
https://worldmedicalinnovation.org/
https://worldmedicalinnovation.org/https://www.youtube.com/channel/UCauKpbsS_hUqQaPp8EVGYOg
Announcement
Aviva Lev-Ari, PhD, RN,
Founder and Director of LPBI Group will be in attendance covering the event in REAL TIME
@pharma_BI
@AVIVA1950
- Reflections on a Four-phase Career: Aviva Lev-Ari, PhD, RN, March 2018
- e-Scientific Publishing: The Competitive Advantage of a Powerhouse for Curation of Scientific Findings and Methodology Development for e-Scientific Publishing – LPBI Group, A Case in Point
- Electronic Scientific AGORA: Comment Exchanges by Global Scientists on Articles published in the Open Access Journal @pharmaceuticalintelligence.com – Four Case Studies
All TWEETS from LPBI’s Twitter.com handles at
#WMIF18
Monday, April 23, 2018
GE Foyer
Nuance Foyer
NVIDIA Ballroom
First Look: The Next Wave of AI Breakthroughs in Health Care
Early career Harvard Medical School investigators kick-off the 2018 World Medical Innovation Forum with rapid fire presentations of their high potential new technologies. Nineteen rising stars from Brigham Health and Massachusetts General Hospital will give ten-minute presentations highlighting their discoveries and insights that will disrupt the field of artificial intelligence. This session is designed for investors, leaders, donors, entrepreneurs and investigators and others who share a passion for identifying emerging high-impact technologies. To view speakers and topics, click here.
3rd Floor and 7th Floor
Discovery Café Workshops
Lunch with Top Leadership from across Partners HealthCare and Industry.
Seven intensive workshops addressing cutting-edge artificial intelligence topics. To view topics and speakers, click here
NVIDIA Ballroom
NVIDIA Ballroom
Reflecting on the Impact of AI at the Bed and the Bench: Chairs Roundtable
Senior clinical leaders, current and past Forum Chairs, will share perspectives on the range of impact of AI on clinical practice. Discussion will highlight the rapid evolution of AI as a practical clinical tool and short and mid-term prospects for adoption in cancer, cardiovascular and neurological care.
NVIDIA Ballroom
Can AI Based Drug Development Feed A Hungry Pipeline?
Given the scarcity of late-stage assets, prolonged timelines and enormous costs of bringing drugs to market, AI-based approaches to target discovery, drug design and drug repurposing hold significant promise to positively disrupt the existing R&D paradigm.
NVIDIA Ballroom
Smart EHRs: AI for All
The first wave of EHR adoption has focused primarily on digitizing the patient record – with a more recent focus on building interactive clinical decision support capabilities. Development and implementation of CDS applications currently requires clinical staff to observe trends in data, develop protocols to act on these trends and work with technical staff to codify the logic into executable form. As NLP and computer vision capabilities become more advanced, algorithms will identify and propose actions reflecting patterns in the data. The panel will discuss existing challenges and whether AI technology will ultimately support an unsupervised learning approach in the EHR to identify trends and possible responses at both the patient and population level?
NVIDIA Ballroom
AI and the Cost of Trials: The Impact of Real World and Real Time Evidence
AI based approaches to conduct faster and more efficient clinical trials are beginning to emerge. Current approaches include applying predictive tools to perform more targeted patient recruitment and more accurate eligibility assessment. Panelists will discuss timelines for AI technology to have a measurable effect on trial cost and time to conduct the trial. Bottlenecks to applying this technology at scale and whether there will be a measurable effect on the cost of bringing drugs to market over the next decade will also be examined.
Nuance Foyer
Leave a Reply